Oncolytics Biotech (oncy) Misses Q3 EPS by 25c
Tweet
Share
E-mailGet Alerts oncy Hot Sheet
Join SI Premium – FREE
Oncolytics Biotech (NASDAQ: oncy) reported Q3 EPS of ($0.02), $0.25 worse than the analyst estimate of $0.23.
For earnings history and earnings-related data on Oncolytics Biotech (oncy) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Femasys Inc. (FEMY) Misses Q2 EPS by 20c
- Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
